← Back to Clinical Trials
Recruiting NCT06802367

NCT06802367 Hospital Environmental Exposure

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06802367
Status Recruiting
Phase
Sponsor University of Leicester
Condition Environment
Study Type OBSERVATIONAL
Enrollment 120 participants
Start Date 2025-04-08
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 120 participants in total. It began in 2025-04-08 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

There is an increasing body of evidence that human health is affected by environmental factors such as air quality, noise and light. This applies to both indoor and outdoor environments. While there have been several studies looking at homes, offices and work environments, hospital environments are still poorly characterised. Indoor hospital environments are complex, and patients with various health conditions can spend extended periods of time in wards. A number of studies have reported an association of air pollution exposure and a disturbance to sleep. A lack of sleep, or poor and disrupted sleep can impact health. Disturbed sleep therefore can impact a patient's recovery in hospital wards. In addition to the exposure to air pollutants, noise and light levels within the hospital environment can also have an impact on patient health. Inadequate, or a disrupted light and dark cycles can impact the circadian rhythm of the human body, responsible for the sleep cycle. In this study, the investigators aim to characterise these exposures and address the impact of these exposures on the patient sleep. Given the links between sleep and the environmental conditions.

Eligibility Criteria

Inclusion Criteria: * Hospital admission with a diagnosis that requires at least 2 nights. * Participant is willing and able to give informed consent for participation in the study. If a patient for example has dementia and/ or the inability to retain information or if they are unable to wear the device, they will not be consented. * Aged 18 years or above. * Able (in the ward staff, research team and investigator's opinion) and willing to comply with all study requirements. Exclusion Criteria: * Any significant disease or disorder which, in the opinion of the investigator, may either put the participants or other patients at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study. * Reported history of sleep disorders, including obstructive sleep apnoea syndrome (OSAS) or insomnia.

Contact & Investigator

Central Contact

Rikesh Panchal, PhD

✉ rp173@leicester.ac.uk

📞 +44(0)116 229 7659

Principal Investigator

Joshua Vande Hey, PhD

STUDY CHAIR

University of Leicester

Frequently Asked Questions

Who can join the NCT06802367 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Environment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06802367 currently recruiting?

Yes, NCT06802367 is actively recruiting participants. Contact the research team at rp173@leicester.ac.uk for enrollment information.

Where is the NCT06802367 trial being conducted?

This trial is being conducted at Leicester, United Kingdom.

Who is sponsoring the NCT06802367 clinical trial?

NCT06802367 is sponsored by University of Leicester. The principal investigator is Joshua Vande Hey, PhD at University of Leicester. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology